We talked with Johns Hopkins psychedelic researcher, Alan Kooi Davis, about the Source Research Foundation, a non-profit awarding grants to students researching psychedelics.

Pulitzer Prize-winning writer Terry Demio talks about reporting on heroin for the Cincinnati Enquirer.

What’s it like being sentenced to life in prison for selling LSD? Timothy Tyler, a Deadhead convicted of selling LSD and granted clemency by President Barack Obama, talked to Psymposia about his 26 years in prison, and the challenges of adjusting to a brave, new world.

Narratives which gloss-over the history and socioeconomic dynamics of ayahuasca’s globalization may, despite good intentions, actually do more harm than good.

Four years since that trip, I’m no longer prescribed antidepressants.

We spoke with an experienced psychiatrist about how exactly prescribing ketamine for depression works.

Clashes between SSDP and New College administrators represent growing confusion about handling harm reduction on campuses

A team of researchers bathed octopuses in MDMA. Here's what they learned.

A conversation between two (white) activists to further the dialogue around inclusivity in the field of psychedelic research and culture.

Today, we have a world where we can say: “I’m proud to be a woman” and “I’m proud to be gay.” But we can’t say: “I’m a drug-user.”

Like the vast majority of psychonauts, I didn’t use a chemical reagent to verify I was taking LSD, even though I had been active in harm reduction work for three years prior and was aware of testing kits.

Before I met Adam I didn’t really know anyone with OCD. It was just an abstract concept to me. Like most people, I had the image of the stereotypical germaphobe who obsessively scrubs their hands in a futile attempt at washing the thousands of bacteria away.

Rhana Hashemi is the site coordinator for drug and alcohol programs and services for Oakland Unified School District. But, to her students, she is just “the drug lady.”

Vincent Horn of Meditate.io talks about psychedelics and meditation.

Think of a glass of water: under normal circumstances you might think ‘I drink water when I’m thirsty’. But when consuming a psychedelic substance you might think ’water is the essence of life’.

We need new drugs. The opioid epidemic gripping the United States has brought into public awareness a problem that has bedeviled the world of medical science for decades: is it possible to have a truly powerful painkiller that is not addictive?

Why researchers like Alan Kooi Davis — the newest addition to the Johns Hopkins psychedelic research team — decide to devote their careers to studying psychedelics.

When two men entered a party in Uneeda Nichols’ home in Washington, D.C. in August 2017 with a couple hundred dollars in cash, they were greeted as cannabis enthusiasts. No one realized they were undercover cops.

I came to a working hypothesis: at the center of the mystical experience is awe, wherein one is in the presence of something so great, so large, that it requires they completely reorder their mental structures - completely change the way they view reality.

As a teenager, I was taking ten milligrams of Ritalin daily. Later, I grew to love the way these pills made it easier for me not to eat.

Renaming adverse effects of psychedelic drugs as “challenging experiences” minimizes, almost trivializes, their negative effects.

I first discovered the potential psychedelics have for treating stuttering during an experience with psilocybin mushrooms.

A candid talk with Arturo Lua Castillo, named Outstanding Student Organizer of 2018 by Students for Sensible Drug Policy.

Meet some of the people on the front lines of global drug reform at The Commission on Narcotic Drugs in Vienna.

The Ibogaine Conversation Conclusion | The goal of this conversation was to provide a platform for a diverse range of perspectives on a single topic. Not everyone agrees, and that’s the point.